Description

BOSUTINIB

BOSUTINIB is an anti-cancer medicine used in the treatment of Leukemia. Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections. BOSUTINIB is used in the treatment of chronic myelogenous leukemia (CML). This medicine is used in patients with chronic, accelerated, or blast phase Ph+ (Philadelphia chromosome-positive) chronic myelogenous leukemia who are resistant or intolerant to prior therapy.

BOSUTINIB contains Bosutinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body.

BOSUTINIB may cause certain side effects, such as rash, fatigue, headache, back pain, decreased platelet count, back pain, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, and dizziness. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. BOSUTINIB should be taken as advised by your doctor. Do not take more than the recommended dose of medicine. Your doctor will decide the dose of BOSUTINIB based on the severity of your condition.

BOSUTINIB should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before taking this medicine, inform your doctor if you have liver/kidney disease, gastrointestinal toxicity, myelosuppression, fluid retention, and hepatic toxicity, as may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment with BOSUTINIB. Breastfeeding should be discontinued in nursing mothers during the treatment. BOSUTINIB is not recommended for use in children below 18 years of age as the safety and efficacy are not established.

Uses of BOSUTINIB

Philadelphia chromosome-positive chronic myeloid leukemia.

Medicinal Benefits

BOSUTINIB contains Bosutinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body.

Directions for Use

Take BOSUTINIB as advised by your doctor. Do not take more than the prescribed dose of medicine. Swallow the medicine as a whole with a glass of water. Do not chew crush or break the medicine.

Storage

Store in a cool and dry place away from sunlight.

Side Effects of BOSUTINIB

• Nausea
• Diarrhoea
• Painful urination
• Decreased platelet count
• Fatigue
• Edema
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Back pain
• Cough
• Dizziness
• Skin rash